FDA Says Ozempic, Wegovy Shortage Resolved

The FDA has declared the shortage of semaglutide (Ozempic, Wegovy) has been resolved, confirming that the US supply of the prescription-only medications now meets or exceeds the current and projected demand. Semaglutide has been in shortage since March (Wegovy) and August (Ozempic) 2022 due to increased demand, according to the FDA.^1,2

The FDA said that there may be intermittent and limited localized supply disruptions due to products moving through the supply chain. | Image Credit: Araki Illustrations | stock.adobe

“We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming that Novo…